SEC Form 5 · accession 0001622340-15-000005
Microlin Bio, Inc · MICB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Reza Noorkayhani
Officer — CEO · Director · 10% Owner
Period of report
Dec 31, 2014
Accepted (ET)
Jan 20, 2015 · 5:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001547530
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 15, 2014 | P | 2,450,000 | $0.001 | A | 3,805,000 | D |
Table II — derivative securities
No Table II lines on this filing.